ARWR - Arrowhead Pharmaceuticals, Inc.

Name: Arrowhead Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Insider activity in ARWR over the last quarter tilts toward selling: insiders offloaded a net 13,600 shares worth roughly $1.2M.

Compare Health Care sector insider flows →

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Christopher Richard Anzalone	3.79M	$225.78M	-
COO	Patrick O'Brien	547.4K	$32.59M	-
Other	James C Hamilton	227.0K	$13.51M	-
CFO	Daniel Joseph Apel	162.9K	$9.70M	-
Dir	Michael S Perry	111.5K	$6.64M	-

Activity

Buys and sells only

Transactions

10 filings · page 10

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 22, 2021	Douglas B Given66	Director	Sell	4,500	$89.21	$401,445.00	-3.8%	-29.8%	-64.5%
Feb 22, 2021	Douglas B Given66	Director	Sell	1,125	$88.73	$99,821.25	-7.5%	-12.0%	-49.3%
Feb 8, 2021	Patrick O'Brien76	General Counsel	Sale+OE	90,000	$88.46	$7,961,240.32	-23.5%	-25.2%	-41.0%
Jan 15, 2021	Douglas B Given66	Director	Sell	3,000	$83.28	$249,840.00	-19.4%	-	-
Jan 14, 2021	James C Hamilton58	Senior Vice President	Sell	10,000	$81.29	$812,941.90	-7.3%	-	-
Jan 12, 2021	Kenneth Allen Myszkowski68	Chief Financial Officer	Sell	13,038	$81.02	$1,056,309.94	-2.9%	-	-
Jan 7, 2021	James Hassard61	Chief Commercial Officer	Sell	15,625	$75.00	$1,171,875.00	-12.5%	-	-
Jan 6, 2021	Patrick O'Brien76	General Counsel	Sell	25,000	$72.41	$1,810,345.62	-7.9%	-	-
Jan 6, 2021	Kenneth Allen Myszkowski68	Chief Financial Officer	Sell	30,625	$72.44	$2,218,477.01	-6.3%	-	-
Jan 6, 2021	James C Hamilton58	Senior Vice President	Sell	38,750	$72.51	$2,809,578.46	-22.1%	-	-

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC